Eisai
4523.T
#2188
Rank
A$12.69 B
Marketcap
A$45.00
Share price
0.34%
Change (1 day)
-1.54%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): A$1.31

According to Eisai's latest financial reports the company's current EPS (TTM) is A$1.30. an increase over its 2024 EPS that were of A$1.47.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025A$1.6411.85%
2024A$1.47-32.63%
2023A$2.185.52%
2022A$2.07-74.01%
2021A$7.96-66.58%
2020A$23.8198.24%
2019A$12.0117.01%
2018A$10.2737.78%
2017A$7.45-27.62%
2016A$10.2935.33%
2015A$7.61-2.82%
2014A$7.83-27.66%
2013A$10.82-27.49%
2012A$14.92-12.67%
2011A$17.0988.08%
2010A$9.09-11.06%
2009A$10.22-390.15%
2008A-$3.52-127.78%
2007A$12.6811.78%
2006A$11.344.38%
2005A$10.877.4%
2004A$10.1243.03%
2003A$7.0725.09%
2002A$5.6652.67%
2001A$3.7069.76%
2000A$2.18